Researchers devise age-based eligibility method to measure vaccine effectiveness in data-deficient scenarios Read more
Amgen announces positive phase-II data for investigational Olpasiran in adults with elevated lipoprotein(a) Read more
US FDA approves Novartis Kymriah CAR-T cell therapy for adult patients with relapsed or refractory Follicular Lymphoma Read more
US FDA grants fast track designation to Pfizer’s ervogastat/clesacostat combination to treat NASH Read more